Simpler Grants.gov #RFA-AR-28-001

NIAMS P30 grants for integrated arthritis, musculoskeletal, and skin disease research Centers

NIAMS is seeking applications for integrated P30 research Centers serving its arthritis, musculoskeletal, and skin disease research mission. - Government buyer: National Institutes of Health (NIH), through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). - Opportunity: Grant support for integrated research Centers focused on skin biology and diseases; bone, muscle, and orthopaedic research; and rheumatic diseases. - Center capabilities: Coordinated research infrastructure, shared resources, and methodological expertise for basic, translational, and clinical research, including analytical methods, study design, outcome measures, and data-driven approaches. - Notable priorities: Multidisciplinary collaboration, workforce development, and training in data science, artificial intelligence, and implementation research. Clinical trials are not allowed. - Funding: $17 million in program funding, with up to 30 expected awards and a stated maximum award of $500,000. - Products, quantities, and vendors: No commercial products, part numbers, quantities, OEMs, or vendors are identified; this is a research grant opportunity rather than a product procurement.

Description

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) requests applications to support integrated research Centers in skin biology and diseases, bone, muscle, and orthopaedic research, and rheumatic diseases. The Centers will provide coordinated research infrastructure, shared resources, and methodological expertise to advance basic, translational, and clinical research. They are expected to integrate advanced research resources with support for clinical and translational research, including development, testing, and dissemination of analytical methods, study designs, outcome measures, and data-driven approaches. The program aims to accelerate discovery, improve research efficiency, strengthen translation of findings into health outcomes, and foster multidisciplinary collaboration and workforce development.

View original listing